Intrinsic Value of S&P & Nasdaq Contact Us

Veracyte, Inc. VCYT NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
70/100
4/7 Pass
SharesGrow Intrinsic Value
$48.21
+40.6%
Analyst Price Target
$44.50
+29.7%

Veracyte, Inc. (VCYT) has a consensus analyst rating of Buy, based on 20 analysts covering the stock. Of those, 13 recommend buying, 6 recommend holding, and 1 recommend selling.

The analyst consensus price target for VCYT is $44.50, representing a +29.7% upside from the current price of $34.3. Price targets range from a low of $37.00 to a high of $50.00.

Analyst Consensus — VCYT

Buy
Strong Buy
0
Buy
13
Hold
6
Sell
1
Strong Sell
0
20 analysts
Price Targets
Consensus$44.50
High$50.00
Low$37.00
Median$45.50
Last Month Avg-
Last Quarter Avg$37.00
Last Year Avg$42.00
All-Time Count11
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message